The healthcare landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a potential development. Unlike shots, this approach offers a less invasive way to administer GLP-1 therapies. These https://abelznzb276905.wizzardsblog.com/40933257/glp-1-patches-a-novel-approach-to-blood-sugar-control